BioMarin announces global settlement with Ascendis over Yuviwel royalties
BioMarin says Ascendis will pay royalties to BioMarin on Yuviwel sales in the U.S., EU, Brazil and South Korea under a global settlement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.